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Objectives Pre- and post-sedation effect of oral Midazolam to promethazine in2-6 yrs old fearful children for dental 
treatment 
Methods This randomized clinical trial was carried out on a group of 26 children aged 2-6 years referred to the dental 
school due to their fear and multiple dental needs. Patients were selected from ASA I or II classification and scored 1 in 
Frankl Behavior scale. Each patient was scheduled for two subsequent visits to receive one of the two pre medications 
before IV sedation. Each patient served as self-control and randomly assigned to either group A: receiving Midazolam 
oral as premed in 1st visit or group B: receiving Promethazine oral as the premed in 1st visit. Six hour NPO was 
instructed prior to sedation visit. Monitoring vital signs were conducted at every 15 minutes starting with base line 
before any drug administration. Sedation score was recorded using Houpt Sedation scale. Post sedation problems were 
recorded by operator. Data were analyzed using Student t test and Kruskal Wallis. 
Results No significant difference was noted between the patient perceptions at the two different visits. Children did not 
show a significant difference on symptoms such as Crying, Movement, Sleep and overall behavior in two visits at the first 
15 minutes of sedative injection. Post-operative complications were having no significant difference. Lower sickness and 
vomiting were reported following promethazine intake. 
Conclusion Promethazine seems to be as effective and as acceptable premedication as Midazolam in pediatric dentistry. 




Treatment of anxious children remains to be a big challenge 
for pediatric dental profession.
1 
It is proved to be difficult 
and in certain cases even impossible to treat these fearful 
young children on a routine setup dental chair.
2 
In these 
circumstances, the use of pharmacological methods comes 
to light in order to enable certain cases to be seen 
effectively. These include the conscious sedation (CS), deep 
sedation and general anesthesia (GA). Since administration 
of GA has several short comes including necessity of 
special training, hospital setup, high cost and longtime 
taken, CS is nowadays advocated as an acceptable 
replacement while cheaper and more convenient to both 
patient and operator in many instances.
3
 Varying methods 
are employed for sedation induction with the oral route as 
being at the top of the list for its ease of use and high 
patient acceptance
4
 In fact oral sedation is acknowledged as 
the oldest known yet effective, economic, and easy to use 
among all routes of CS
5
 Nasal, Rectal, IV and IM routes are 
also other ways of induction routinely used in certain cases 
with their own advantages and limitations.
5
 High patient 
acceptance is the key advantage of the oral routes in 
children of the families not interested in forced treatment. 
Midazolam is widely and readily available in an oral dosage 
as a sedative hypnotic agent. Peak action occurs after 30 
minutes of oral administration. It has been employed orally 
as the sole sedative agent as well as in combination as 
premedication prior to other sedative agents before medical 
and dental surgical procedures for adults and children.
6-8
 
Promethazine is a Phenothiazine derivative commonly used 
as an antiemetic for management of nausea and vomiting, 
for preoperative sedation, main sedation as to relief the 
apprehension and anxiety, light sleep with easily aroused 
and management of allergy Midazolam is a short -acting but 
fast and effective benzodiazepine and its sedative and 
anxiolytic effects begin 20 minutes after oral 
administration. Promethazine, in the other hand is a long 
acting antihistaminic and anti-vomiting agent. 
Ketamine hydrochloride is a Cyclohexane derivative 
closely related chemically and pharmacologically to 
phencyclidine, a veterinary anesthetic and drug abuse 
known as “angel dust”.
1
 
This clinical trial was designed to evaluate the post sedation 
side effects of oral Midazolam and Promethazine 
premedication in an IV ketamine sedated pediatric dental 
service.  
 
Materials and Methods 
 
This randomized cross over clinical trial was designed in a 
double blind manner (IRCT Reg No: 2016120516106N3). 
A total of 26 uncooperative children aged 2-6 years were 
included who were judged by an anesthesiologist as 
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medically fit for conscious sedation and stand in ASA I. 
Dental behavior scaling was conducted and only those in 
Frankl I score were included in this investigation. Cases 
were divided into two groups randomly in order to enable 
evaluation of the carry over effect by having each case act 
as self-control receiving medications in different orders. 
Attempts were made to ensure each case has at least 2 
similar dental needs on similar teeth of the other side on the 
same jaw to simulate the treatment sessions. 
Informed consent was sought from individuals prior to each 
treatment session. Randomly assigned cases into one of the 
two groups of A and B were subjected to premedication as 
follows:  
Group A: received Midazolam (Amsed, UK) Atropine 
(Alborz Daroo, Iran) (0.5mg/kg, 0.25mg, respectively) as 
oral premed at their1
st




Group B: received the same regimen but in an opposite 
order 
Patients were instructed to observe a 6 hour NPO prior to 
the sedative drugs administration step. The oral sedative 
drug’s onset time was expected to be at and around 30-45 
min of intake. A clinical evaluation of the sedation level 
was carried out prior to the main IV sedative administration 
of Ketamine (Rotex medica, Germany) & Midazolam 
(Abooreihan, Iran) (2mg/kg, 0.1 mg/kg) and treatment 
completed. Evaluation steps were continued at treatment 
end, one, two and six hours post-operative through the 
phone interviewing Mum. 
Physiologic signs were recorded and parameters evaluated 
were: Heart Rate, Respiratory Rate, SPO2, Blood Pressure 
changes throughout the procedure. These signs were 
recorded at start, During LA injection, at 15 min and 30 min 
of starting dental procedure. 
HOUPT scale was used to evaluate and classify each cases 
Behavior parameters with the following details: Crying (C), 
Sleepiness (S), Movement (M) & Overall Behavior 




and 6 hours post 
operatively which include possible any possible: Vomiting, 
Nausea, Dizziness, Sleepiness. Collected data were 
analyzed using student t-test (s) and the level of 
significance was (p<0.05). Non parametric Kruscal Wallis 
test was used to analyze the level of sedative effect on each 




In total 26 uncooperative children aged 2-6 years who 
scored as Frank l I, with weight ranged 8-20kg were 
included in this study (Tables 1). 
Differences were not statistically significant (P>0.05) for 
child’s Behavior Parameters, Physiologic Parameters, 
Recovery time, and side effects when their first and second 
visits were compared (Figures 1 and 2). 
However there was a significant difference between the two 
groups when nausea and sleepiness were compared 
(p<0.05) in 1and 2 hours post operatively. No Significant 
differences were found between the two groups (p>0.05) 
for their side effects. There was however minimal 
difference in favor of Promethazine for reduce vomiting 
rate 
 .Table 1- Distribution of Age and Weight among children 
of this investigation 





2 - 3 16 64 
3- 4 5 20 
4 - 5 4 16 
Total 25 100 
Weight 
8 - 12 3 12 
12 - 16 16 64 
16 - 20 6 24 
Total 25 100 
 
 
Figure 1- Bar Chart showing the rate of various side effects following 
the use of both premedication regimens 
 
Figure 2: Bar chart showing the difference between sleepiness at 




Every day growing preference for sedation and GA dental 
treatment emerges for treatment of highly anxious and very 
young children.
5, 9-11
 To date, a large number of researches 
have reported the necessity as well as safety, efficacy and 
potential side effects of the techniques and drugs involved 
in various sedation approached at the dental practices. 
Mathai et al. (2014) looked at the rapid onset in intranasal 
midazolam and oral Promethazine in preschool children 
with higher results in favor of Midazolam.
12
 Fallah et al. 
(2014) stated that side effects of Promethazine and chloral 
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significant difference between groups.
13
 Behetwar et al. 
(2011) reported slower onset and faster recovery in children 
receiving midazolam or ketamine alone compare to those 
received combination of the two.
14 
Bui and Ronald (2002) 
evaluated the efficacy of oral ketamine versus oral 
Ketamine and Promethazine with Ketamine alone proved to 
be more efficient than their combined administration.
15 
Dolman et al. (2001) evaluated the efficacy and safety of 
intranasal midazolam and oral chloral hydrate and oral 
Promethazine. Lower systolic pressure were reported in 
Promethazine and chloral hydrate and a delayed recovery in 
midazolam.
16 
In current trial, the side effects of oral 
Midazolam and Promethazine premedication were almost 
similar and ignorable. 
There was no significant differences between the two 
groups when HOUPT scale was compared for children’s 
sedative reactions (p>0.05).Similarly no significant 
differences was found between the physiologic parameters 
and side effects of each pre-medications regimen at the two 
intervals. Mathai et al. (2014) and Derakhshan et al. (2013) 
reported no significant difference between the levels of 
sedation induced by oral midazolam and oral Promethazine. 
Although they referred to rapid onset as a pharmacologic 
advantage of midazolam beside shorter duration to maximal 
sedation which accelerates patient’s recovery.
12, 17
 
Surprisingly no such differences were observed by Singh et 
al. (2002).
18
 It was concluded that oral midazolam is a 
preferred sedative drug when compared to Promethazine 
and oral Triclofan.
18
 A significant difference was noted 
between the rate of sleepiness after 2 hours (more 
sleepiness in Promethazine group) and nausea after the 1
st
 
hour of treatment (less nausea in Promethazine group) in 
this investigation. 
Derakhshan et al. (2013) stated that except nausea and 
vomiting there was no significant difference between 
complications following the introduction of two drugs with 
both having a similar sedative effect in children. Shorter 
onset of sedation and short duration to peak sedation were 
considered as Midazolam advantage in an out-patient 
setting, while a quick recovery with lesser nausea and 




Promethazine is one of the most frequently used drugs for 
the treatment of nausea and vomiting while it has some 
degree of potential sedative effects.
19-21
 
Mathai et al. (2014), Derakhshan et al. (2013) and Pfeil et 
al. (2008) indicated that there were no significant 
differences in hemodynamic changes between various 
groups when they received similar drugs through different 
routes of administration.
12, 17, 19
 There are also concerns over 
the safe administration of many of these sedative agents 
including antihistaminic agents such as Promethazine for 
under the age of three.
22
  
However there were several limitations to the current 
investigation include sample selection and compliance, 
behavior variations, parents being the responders.  
Conclusion 
Based on the findings of this investigation, it is concluded 
that both medications could be used for reduction of the 
anxiety before and during certain medical and dental 
treatment processes. 
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